drugset / Trial / NCT07153003

Efficacy And Safety Of Tramadol And Oxycodone Versus Oxycodone Monotherapy For Pain Control After Primary Total Knee And Total Hip Arthroplasty

NCT07153003

Phase 4 Enrolling by invitation 560 enrolled Mayo Clinic
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the effectiveness and safety of tramadol and oxycodone therapy in comparison to oxycodone alone as part of a multimodal pain regimen to reduce postoperative opioid consumption, pain, minimize adverse events and complications for primary total knee arthroplasty (TKA) and primary total hip arthroplasty (THA).

Timeline

Start
2026-02-02
Primary completion
2030-09-01
Completion
2031-09-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Oxycodone Other / unclassified 2.5 mg Oral
Comparator Oxycodone Other / unclassified 5 mg Oral
Comparator Oxycodone Other / unclassified 10 mg Oral
Comparator Tramadol Other / unclassified 50 mg Oral
Comparator Tramadol Other / unclassified 100 mg Oral

Indications

No indication recorded.